| Gonal-f RFF RediJect |
021684 |
002 |
351(a) |
follitropin alfa |
Injection |
Subcutaneous |
450IU/0.75ML |
Autoinjector |
2004/05/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f RFF RediJect |
021684 |
003 |
351(a) |
follitropin alfa |
Injection |
Subcutaneous |
900IU/1.5ML |
Autoinjector |
2004/05/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Octagam |
125062 |
001 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 5.0G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
002 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 1.0G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
003 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 10G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
004 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 2.5G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Vitrase |
021640 |
001 |
351(a) |
hyaluronidase |
Injection |
Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous |
6,200UNITS/ML |
Single-Dose Vial |
2004/05/05
|
Bausch & Lomb Incorporated |
Disc |
Licensed |
N/A |
N/A |
| Novolog |
020986 |
004 |
351(a) |
insulin aspart |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2004/04/23
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |
| Apidra |
021629 |
001 |
351(a) |
insulin glulisine |
Injection |
Intravenous, Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
2004/04/16
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f |
020378 |
005 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
450IU (600IU/ML) |
Multi-Dose Vial |
2004/03/26
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f |
020378 |
003 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
37.5IU |
Ampule |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
001 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
37.5IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
002 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
75IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
003 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
150IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Follistim AQ Cartridge |
021211 |
001 |
351(a) |
follitropin beta |
Injection |
Subcutaneous |
300IU/0.36ML |
Multi-Dose Cartridge |
2004/03/23
|
Organon USA LLC, a subsidiary of Organon & Co. |
Rx |
Licensed |
N/A |
N/A |
| Follistim AQ Cartridge |
021211 |
002 |
351(a) |
follitropin beta |
Injection |
Subcutaneous |
600IU/0.72ML |
Multi-Dose Cartridge |
2004/03/23
|
Organon USA LLC, a subsidiary of Organon & Co. |
Rx |
Licensed |
N/A |
N/A |
| Monoclate, Monoclate-P |
103953 |
004 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
1500IU |
Vial |
2004/03/04
|
CSL Behring LLC |
Disc |
Voluntarily Revoked |
|
N/A |
| Avastin |
125085 |
001 |
351(a) |
bevacizumab |
Injection |
Intravenous |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
2004/02/26
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Avastin |
125085 |
002 |
351(a) |
bevacizumab |
Injection |
Intravenous |
400MG/16ML (25MG/ML) |
Single-Dose Vial |
2004/02/26
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rhophylac |
125070 |
001 |
351(a) |
Rho(D) Immune Globulin Intravenous (Human) |
Injection |
Intramuscular |
1500IU/ML |
Pre-Filled Syringe |
2004/02/12
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |